Central America Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
73 Pages - SKU: BMI5329127
Countries covered: Central America

Central America Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namelyEl Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapitamedicine spending and strong consumer demand still present strong revenue-generatingopportunities for multimodal pharmaceutical companies.

Headline Expenditure Projections

Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to less promising industry data.

Healthcare: USD16.0bn in 2013 to USD16.8bn in 2014; +4.8 %. Our forecast has been reviseddownwards since Q314 due to revised historical data.



More Prescription Drugs reports by Business Monitor International

Sweden Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sweden Pharmaceuticals and Healthcare Report Q1 2015BMI View: Declining government reimbursement for prescription medicines does not bode well forinnovative drugmakers selling their products in Sweden, ...
Pakistan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Pakistan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Pakistan holds great potential for pharmaceutical and healthcare companies, with the world'ssixth largest population. However, poor medical ...
Nigeria Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Nigerian government remains committed to improving healthcare quality andinfrastructure across the country. The formation of the ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare Report Q1 2015BMI View: With New Zealand's population ageing rapidly, underlying demand for health services andpharmaceuticals is high for the ...
See all reports like this >>

More Central America Prescription Drugs reports

Antibiotics Market in Panama to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Panama. The study provides essential market ...
See all reports like this >>

More Central America reports

D&B Country Report: Guatemala by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
D&B Country Report: El Salvador by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!